A Study of LAD106 in Healthy Adult Participants — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of LAD106 in Healthy Adult Participants — Stella

Home/Healthy Volunteers/

View on ClinicalTrials.gov

Recruiting

Back to Healthy Volunteers trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Netherlands

Centre for Human Drug Research (CHDR) Phase 1 Unit, Leiden

Key details

Phase

Early testing

Sponsor

Almirall, S.A.

Enrollment target

~93 participants

Started

February 2026

Primary completion

June 2026

Age range

18 Years – 45 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.